UA104644U - The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis - Google Patents

The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis

Info

Publication number
UA104644U
UA104644U UAU201507818U UAU201507818U UA104644U UA 104644 U UA104644 U UA 104644U UA U201507818 U UAU201507818 U UA U201507818U UA U201507818 U UAU201507818 U UA U201507818U UA 104644 U UA104644 U UA 104644U
Authority
UA
Ukraine
Prior art keywords
progression
threats
diagnosis
pulmonary sarcoidosis
inflammatory activity
Prior art date
Application number
UAU201507818U
Other languages
Ukrainian (uk)
Inventor
Костянтин Вікторович Швець
Микола Миколайович Островський
Original Assignee
Костянтин Вікторович Швець
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Костянтин Вікторович Швець filed Critical Костянтин Вікторович Швець
Priority to UAU201507818U priority Critical patent/UA104644U/en
Publication of UA104644U publication Critical patent/UA104644U/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Спосіб діагностики активності запального процесу та загрози прогресування саркоїдозу легень включає проведення загальноклінічних методів обстеження, при якому додатково визначають вміст С-реактивного білка та ІЛ-2 в бронхо-альвеолярному вмісті, та при їх показниках у бронхо-альвеолярному вмісті (28,34±2,45) мг/л і (196,72±8,13) пг/мл відповідно і вище діагностують передумови загрози активації запального процесу та прогресування саркоїдозу у хворих.A method of diagnosing the activity of the inflammatory process and the threat of progression of pulmonary sarcoidosis involves conducting general clinical examination methods, which additionally determine the content of C-reactive protein and IL-2 in the broncho-alveolar content, and at their rates in the broncho-alveolar content (28,34 ± 2 , 45) mg / l and (196,72 ± 8,13) pg / ml respectively and above diagnose the prerequisites for the threat of activation of the inflammatory process and the progression of sarcoidosis in patients.

UAU201507818U 2015-08-06 2015-08-06 The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis UA104644U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201507818U UA104644U (en) 2015-08-06 2015-08-06 The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201507818U UA104644U (en) 2015-08-06 2015-08-06 The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis

Publications (1)

Publication Number Publication Date
UA104644U true UA104644U (en) 2016-02-10

Family

ID=55701184

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201507818U UA104644U (en) 2015-08-06 2015-08-06 The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis

Country Status (1)

Country Link
UA (1) UA104644U (en)

Similar Documents

Publication Publication Date Title
MX2018012580A (en) Methods and kits for the diagnosis and risk stratification of patients with ischemia.
WO2018089693A3 (en) Methods for determining and monitoring gastrointestinal inflammation
MX2017015260A (en) Anti-gitr antibodies for cancer diagnostics.
CY1124698T1 (en) IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES
WO2014201516A3 (en) Biomarker identification
BR112014018592A2 (en) composition and method for the diagnosis and treatment of diseases associated with neuronal degeneration
MX2018001697A (en) Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers.
EP3974450A3 (en) Biomarker
MX2020006660A (en) Biomarkers of methotrexate-induced immune tolerance.
WO2018026969A3 (en) Plazomicin antibodies and methods of use
UA104644U (en) The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis
RU2014113841A (en) METHOD FOR EARLY DIAGNOSTICS OF ENDOGENOUS INTOXICATION
UA97881U (en) METHOD OF DIAGNOSIS OF THE THREAT OF DEVELOPMENT AND PROGRESSION OF SECONDARY BRONCHOEKTAS IN PATIENTS WITH CHRONIC Bronchitis
MX2018006250A (en) Biomarker of polycystic kidney disease and uses thereof.
WO2015193738A3 (en) Methods and biomarkers for analysis of colorectal cancer
WO2015158608A3 (en) Diagnosis of chronic kidney disease by quantitative analysis of post-translational modifications of plasma proteins
EP3862438A4 (en) Acute renal failure-specific biomarker, acute renal failure diagnosis method, acute renal failure test kit, animal treatment method and acute renal failure medication
UA93328U (en) Method for predicting failure of union in fracture
UA96277U (en) The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
UA93315U (en) Method for diagnosing failure of union in fracture
UA109515U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
UA93325U (en) Method for diagnosing fracture union
RU2014121297A (en) METHOD FOR DIAGNOSTIC OF CHRONIC HEART FAILURE
UA114329U (en) METHOD OF DIAGNOSTICS OF ATHEROSCLEROSIS DEVELOPMENT
UA108352U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT